Adam Seth Cifu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Adam Seth Cifu has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
- Vinay Prasad
Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, USA
9 shared publications Jonathan Paul
University of Chicago, Chicago, Illinois
3 shared publicationsAlexander Chaitoff
Brigham and Women's Hospital, Boston, Massachusetts
1 shared publicationAndrae L. Vandross
Ronald Reagan UCLA Medical Center, Los Angeles, Calif
1 shared publicationAndrew D. Beaser
University of Chicago, Chicago, Illinois
1 shared publication- Andrew D. Beaser
Section of Cardiology, University of Chicago, IL (A.D.B.).
1 shared publication
Latest Publications
- 22 February 2023
- Published by Oxford University Press (OUP) in Academic Medicine
- Vol. 98 (Supplement) , S37-S38
Well, That Could Have Gone Better
Most physician–patient relationships take little effort. The physician acts with the kindness, patience, empathy, and professionalism that they have brought to the field and honed over years of training and practice. However, there are a subset of patients with whom, to be successful, the doctor needs insight into their own weaknesses and countertransference. In this reflection, the author recounts his troubled relationship with a patient. The source of the tension was the physician’s countertransference. Self-awareness allows a physician to understand how countertransference can threaten good medical care and how it can be managed.
- 22 February 2023
- Published by Oxford University Press (OUP) in Academic Medicine
- Vol. 98 (Supplement) , S37-S38
Well, That Could Have Gone Better
Most physician–patient relationships take little effort. The physician acts with the kindness, patience, empathy, and professionalism that they have brought to the field and honed over years of training and practice. However, there are a subset of patients with whom, to be successful, the doctor needs insight into their own weaknesses and countertransference. In this reflection, the author recounts his troubled relationship with a patient. The source of the tension was the physician’s countertransference. Self-awareness allows a physician to understand how countertransference can threaten good medical care and how it can be managed.
- 16 February 2023
- Published by Oxford University Press (OUP) in Academic Medicine
- Vol. 98 (Supplement) , S1-S2
Preface
An abstract is unavailable. This article is available as a PDF only.
- 16 February 2023
- Published by Oxford University Press (OUP) in Academic Medicine
- Vol. 98 (Supplement) , S1-S2
Preface
An abstract is unavailable. This article is available as a PDF only.
- Open Access
- 4 October 2022
- Published by American Medical Association (AMA) in JAMA
- Vol. 328 (13) , 1346-1347
Management of Heart Failure
Since the 2017 publication of the ACC/AHA/HFSA focused update of HF guidelines, multiple clinical trials have demonstrated the significant benefits of novel medical therapies for patients with HF across the spectrum of EF.1-4 The emergence of these therapies adds nuance and complexity to the care of patients with HF.
- 4 October 2022
- Published by American Medical Association (AMA) in JAMA
- Vol. 328 (13) , 1346-1347
Open AccessManagement of Heart Failure
Since the 2017 publication of the ACC/AHA/HFSA focused update of HF guidelines, multiple clinical trials have demonstrated the significant benefits of novel medical therapies for patients with HF across the spectrum of EF.1-4 The emergence of these therapies adds nuance and complexity to the care of patients with HF.
- Open Access
- 9 August 2022
- Published by American Medical Association (AMA) in JAMA
- Vol. 328 (6) , 575-576
Therapy for Mild to Moderate Asthma
Asthma is a disease characterized by recurring, reversible airways obstruction due to underlying inflammation and bronchial hyperresponsiveness. Asthma is one of the most common chronic noncommunicable diseases, affects an estimated 260 million people globally, and is associated with significant morbidity and mortality.1 Asthma with usually mild or infrequent symptoms (50%-75% of patients with asthma) contributes to 30% to 40% of exacerbations leading to emergency care; asthma-related death may occur in persons with asthma that is usually mild.2
- 9 August 2022
- Published by American Medical Association (AMA) in JAMA
- Vol. 328 (6) , 575-576
Open AccessTherapy for Mild to Moderate Asthma
Asthma is a disease characterized by recurring, reversible airways obstruction due to underlying inflammation and bronchial hyperresponsiveness. Asthma is one of the most common chronic noncommunicable diseases, affects an estimated 260 million people globally, and is associated with significant morbidity and mortality.1 Asthma with usually mild or infrequent symptoms (50%-75% of patients with asthma) contributes to 30% to 40% of exacerbations leading to emergency care; asthma-related death may occur in persons with asthma that is usually mild.2
- Open Access
- 26 July 2022
- Published by American Medical Association (AMA) in JAMA
- Vol. 328 (4) , 389-390
Obesity and Weight Management for Prevention and Treatment of Type 2 Diabetes
Type 2 diabetes is a disease characterized by insulin resistance and pancreatic β-cell dysfunction resulting in hyperglycemia. An estimated 34 million people in the US (about 1 in 10) have diabetes, of whom an estimated 90% to 95% have type 2 diabetes.1 The risk of type 2 diabetes increases with obesity, and weight loss is associated with improved glycemic control. Both obesity and type 2 diabetes increase risk of cardiovascular disease, a leading cause of death in the US.
- 26 July 2022
- Published by American Medical Association (AMA) in JAMA
- Vol. 328 (4) , 389-390
Open AccessObesity and Weight Management for Prevention and Treatment of Type 2 Diabetes
Type 2 diabetes is a disease characterized by insulin resistance and pancreatic β-cell dysfunction resulting in hyperglycemia. An estimated 34 million people in the US (about 1 in 10) have diabetes, of whom an estimated 90% to 95% have type 2 diabetes.1 The risk of type 2 diabetes increases with obesity, and weight loss is associated with improved glycemic control. Both obesity and type 2 diabetes increase risk of cardiovascular disease, a leading cause of death in the US.
- Open Access
- 19 July 2022
- Published by American Medical Association (AMA) in JAMA
- Vol. 328 (3) , 292-293
Evaluation and Diagnosis of Chest Pain
Chest pain is a common problem in the emergency department (ED), yet only 5.1% of patients presenting with chest pain are diagnosed with an acute coronary syndrome (ACS).1 Given the high frequency of chest pain in the ED, the high risk associated with ACSs, and the high prevalence of coronary heart disease, the evaluation of acute chest pain is associated with significant clinical uncertainty, unnecessary testing, resource use, and cost implications. The complete guideline addresses both acute and stable chest pain; this synopsis focuses on the major recommendations for diagnosing acute chest pain.
- 19 July 2022
- Published by American Medical Association (AMA) in JAMA
- Vol. 328 (3) , 292-293
Open AccessEvaluation and Diagnosis of Chest Pain
Chest pain is a common problem in the emergency department (ED), yet only 5.1% of patients presenting with chest pain are diagnosed with an acute coronary syndrome (ACS).1 Given the high frequency of chest pain in the ED, the high risk associated with ACSs, and the high prevalence of coronary heart disease, the evaluation of acute chest pain is associated with significant clinical uncertainty, unnecessary testing, resource use, and cost implications. The complete guideline addresses both acute and stable chest pain; this synopsis focuses on the major recommendations for diagnosing acute chest pain.
- 15 February 2022
- Published by American Medical Association (AMA) in JAMA
- Vol. 327 (7) , 676-677
Diagnosis of Lyme Disease
This JAMA Clinical Guidelines Synopsis summarizes the diagnosis portion of a 2020 practice guideline on Lyme disease.
- 15 February 2022
- Published by American Medical Association (AMA) in JAMA
- Vol. 327 (7) , 676-677
Diagnosis of Lyme Disease
This JAMA Clinical Guidelines Synopsis summarizes the diagnosis portion of a 2020 practice guideline on Lyme disease.
- 5 October 2021
- Published by American Medical Association (AMA) in JAMA
- Vol. 326 (13) , 1321-1322
Inferior Vena Cava Filters for the Treatment of Patients With Venous Thromboembolic Disease
This JAMA Clinical Guidelines Synopsis summarizes the clinical practice guideline from the Society of Interventional Radiology regarding use of inferior vena ca
- 5 October 2021
- Published by American Medical Association (AMA) in JAMA
- Vol. 326 (13) , 1321-1322
Inferior Vena Cava Filters for the Treatment of Patients With Venous Thromboembolic Disease
This JAMA Clinical Guidelines Synopsis summarizes the clinical practice guideline from the Society of Interventional Radiology regarding use of inferior vena ca
- 10 August 2021
- Published by American Medical Association (AMA) in JAMA
- Vol. 326 (6) , 563-564
Management of Patients With Microhematuria
The prevalence of microhematuria among healthy patients ranges from 2.4% to 31.1%.1 Although 13.1% of gross hematuria episodes are associated with malignancy, only 0.3% to 6.3% (depending on population) of microhematuria episodes are associated with malignancy.2,3
- 10 August 2021
- Published by American Medical Association (AMA) in JAMA
- Vol. 326 (6) , 563-564
Management of Patients With Microhematuria
The prevalence of microhematuria among healthy patients ranges from 2.4% to 31.1%.1 Although 13.1% of gross hematuria episodes are associated with malignancy, only 0.3% to 6.3% (depending on population) of microhematuria episodes are associated with malignancy.2,3
- Open Access
- 1 June 2021
- Published by Journal of Graduate Medical Education in Journal of Graduate Medical Education
- Vol. 13 (3) , 321-322
What Just Happened? The NRMP 2020–2030: A Speculative Fiction
As we turn the calendar to 2030, it seems appropriate to reflect on the 2020s. Since the residency matching system began in 1952, no decade has seen such enormous and consequential change.1 Nine years ago, in 2021, after a year marked by a pandemic, the Federation of State Medical Boards and the National Board of Medical Examiners (NBME) stopped requiring the United States Medical Licensing Examination (USMLE) Step 2 CS. Then, on January 26, 2022 the NBME stopped releasing 3-digit scores for the USMLE Step 1. These 2 decisions began a decade of change that has revolutionized medical training. With a new decade upon us, what can we learn from the events of the one just finished?The National Resident Matching Program proceeded in its usual fashion for the graduating classes of 2023 and 2024, but events were conspiring to make the process less workable. First, the newly formed National Medical Student Collective lobbied for the eradication of all clinical assessments during medical school. The Collective argued that clinical assessments were subjective, without proven predictive power, and biased.2 Medical school faculty, exhausted by how contentious grading had become, supported the Collective's call. The Association of American Medical Colleges acquiesced and mandated pass/fail grading systems across all 4 years.In the absence of data to discriminate among applicants, residency program directors were left with little data to compare applicants. By 2024, application packets contained only a Medical Student Performance Evaluation that attested to the applicant's competency and 2 supportive letters of recommendation. An analysis of the language used in these letters demonstrated that the 3 most common descriptors used were outstanding, extraordinary, and stellar. Given the absence of assessments, all honorifics and student awards had also been abandoned. Student research productivity during medical school, once heralded as a reliable indicator of initiative, creativity, fortitude, and commitment, was also no longer considered an asset by residency selection committees. Data generated by career medical education investigators had demonstrated that publications and presentations did not predict future research activity, research quality, or residency performance.Medical students, unable to reliably predict their competitiveness for specific residency programs (or even specific specialties), began applying to greater and greater numbers of programs, and concurrently to multiple specialties. While students in the late 2010s were applying to 30 to 70 programs in order to match, by 2025 the median number of programs to which students applied rose to 97, with 65% of students applying to more than 3 different specialties. Residency program directors, desperate to limit the number of applications, began requiring students to complete supplemental essays to gauge interest. This decision was quickly reversed, however, once selection committees realized these essays were predominantly being generated by artificial intelligence software freely shared by the Collective.Assembling a reliably skilled residency class became so challenging that in 2026 the program directors took decisive action. Declaring that it was impossible to rank students solely on a score on the USMLE Step 2 CK and a brief virtual interview, the newly organized National Council of Program Directors agreed to only consider students from the 25 School Federation, a group of schools ranked highest by the robust, peer-reviewed metrics of US News & World Report. In distinguishing among the students from these institutions, residency selection committees looked to students' undergraduate college transcripts and Medical College Admissions Test scores for additional data points.This is when the NRMP took its unprecedented step and replaced the 2027 Match with a lottery system. It bears remembering that many medical schools had already accepted the inevitability of randomness in the selection process for medical school entry.3,4 What occurred over the next 3 years was startling but, in retrospect, predictable.After a brief peak in 2020, applications to medical schools fell precipitously, as the 2020 COVID-19 pandemic and the economic boom (what was already being referred to as the “Roaring 20s 2.0”) made a career in medicine less attractive. Schools that had been offering free tuition since the late 2010s could no longer do so as funds had to be diverted to repay pandemic-related debt or were earmarked for research into the microbiome. The institutions that made up the 25 School Federation (primarily expensive private medical schools) were unable to fill their classes as students refused to pay higher tuition without foreseeable benefit. These schools began to compete for a few students of enormous means, offering luxuries such as weekly craft classes and comfort animals. The cache of these schools fell as they garnered reputations as mere medical finishing schools.Students who entered medical school encountered an educational environment in which all external incentives to excel had been removed. Medical schools remained dedicated to training the physicians of the future but had to adjust to 2 realities: dependence on tuition dollars for survival, and striking a balance between incentivizing mastery while not incurring the wrath of the Collective by demanding too much in the way of challenging coursework or full days of engaging in patient care. All schools increased class size to maximize tuition income.Residency programs became the educational engine of medicine, but faced the conflicting aims of providing medical care while meeting the demands of the health care quality metrics set forth by the Universal Care Act of 2027 (commonly referred to as EMACA—the Even More Affordable Care Act). Residencies are now using the money allocated in EMACA to match twice the number of residents needed (at markedly reduced salaries)....
- 1 June 2021
- Published by Journal of Graduate Medical Education in Journal of Graduate Medical Education
- Vol. 13 (3) , 321-322
Open AccessWhat Just Happened? The NRMP 2020–2030: A Speculative Fiction
As we turn the calendar to 2030, it seems appropriate to reflect on the 2020s. Since the residency matching system began in 1952, no decade has seen such enormous and consequential change.1 Nine years ago, in 2021, after a year marked by a pandemic, the Federation of State Medical Boards and the National Board of Medical Examiners (NBME) stopped requiring the United States Medical Licensing Examination (USMLE) Step 2 CS. Then, on January 26, 2022 the NBME stopped releasing 3-digit scores for the USMLE Step 1. These 2 decisions began a decade of change that has revolutionized medical training. With a new decade upon us, what can we learn from the events of the one just finished?The National Resident Matching Program proceeded in its usual fashion for the graduating classes of 2023 and 2024, but events were conspiring to make the process less workable. First, the newly formed National Medical Student Collective lobbied for the eradication of all clinical assessments during medical school. The Collective argued that clinical assessments were subjective, without proven predictive power, and biased.2 Medical school faculty, exhausted by how contentious grading had become, supported the Collective's call. The Association of American Medical Colleges acquiesced and mandated pass/fail grading systems across all 4 years.In the absence of data to discriminate among applicants, residency program directors were left with little data to compare applicants. By 2024, application packets contained only a Medical Student Performance Evaluation that attested to the applicant's competency and 2 supportive letters of recommendation. An analysis of the language used in these letters demonstrated that the 3 most common descriptors used were outstanding, extraordinary, and stellar. Given the absence of assessments, all honorifics and student awards had also been abandoned. Student research productivity during medical school, once heralded as a reliable indicator of initiative, creativity, fortitude, and commitment, was also no longer considered an asset by residency selection committees. Data generated by career medical education investigators had demonstrated that publications and presentations did not predict future research activity, research quality, or residency performance.Medical students, unable to reliably predict their competitiveness for specific residency programs (or even specific specialties), began applying to greater and greater numbers of programs, and concurrently to multiple specialties. While students in the late 2010s were applying to 30 to 70 programs in order to match, by 2025 the median number of programs to which students applied rose to 97, with 65% of students applying to more than 3 different specialties. Residency program directors, desperate to limit the number of applications, began requiring students to complete supplemental essays to gauge interest. This decision was quickly reversed, however, once selection committees realized these essays were predominantly being generated by artificial intelligence software freely shared by the Collective.Assembling a reliably skilled residency class became so challenging that in 2026 the program directors took decisive action. Declaring that it was impossible to rank students solely on a score on the USMLE Step 2 CK and a brief virtual interview, the newly organized National Council of Program Directors agreed to only consider students from the 25 School Federation, a group of schools ranked highest by the robust, peer-reviewed metrics of US News & World Report. In distinguishing among the students from these institutions, residency selection committees looked to students' undergraduate college transcripts and Medical College Admissions Test scores for additional data points.This is when the NRMP took its unprecedented step and replaced the 2027 Match with a lottery system. It bears remembering that many medical schools had already accepted the inevitability of randomness in the selection process for medical school entry.3,4 What occurred over the next 3 years was startling but, in retrospect, predictable.After a brief peak in 2020, applications to medical schools fell precipitously, as the 2020 COVID-19 pandemic and the economic boom (what was already being referred to as the “Roaring 20s 2.0”) made a career in medicine less attractive. Schools that had been offering free tuition since the late 2010s could no longer do so as funds had to be diverted to repay pandemic-related debt or were earmarked for research into the microbiome. The institutions that made up the 25 School Federation (primarily expensive private medical schools) were unable to fill their classes as students refused to pay higher tuition without foreseeable benefit. These schools began to compete for a few students of enormous means, offering luxuries such as weekly craft classes and comfort animals. The cache of these schools fell as they garnered reputations as mere medical finishing schools.Students who entered medical school encountered an educational environment in which all external incentives to excel had been removed. Medical schools remained dedicated to training the physicians of the future but had to adjust to 2 realities: dependence on tuition dollars for survival, and striking a balance between incentivizing mastery while not incurring the wrath of the Collective by demanding too much in the way of challenging coursework or full days of engaging in patient care. All schools increased class size to maximize tuition income.Residency programs became the educational engine of medicine, but faced the conflicting aims of providing medical care while meeting the demands of the health care quality metrics set forth by the Universal Care Act of 2027 (commonly referred to as EMACA—the Even More Affordable Care Act). Residencies are now using the money allocated in EMACA to match twice the number of residents needed (at markedly reduced salaries)....